IP Library › Granted Patent US 12,357,443
Granted Patent B2
US 12,357,443 · App. 17/730,214 · Granted Jul 15, 2025

Benign prostatic hyperplasia treatment device

Inventors: Yoon Ho Chung (Seoul, KR); Geon Sun Park (Seoul, KR)
Assignee: CEDARS HEALTH INC.
A61F2/0045A61B17/3468A61F2220/0075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,443
App. No.
17/730,214
Granted
Jul 15, 2025
Kind
B2
Abstract

Disclosed herein is a benign prostatic hyperplasia treatment device. The benign prostatic hyperplasia treatment device includes: anchor assemblies including a first anchor arranged at the outer surface of the prostate gland, which obstructs the prostatic urethra, a second anchor arranged inside the prostate gland to be opposed to the first anchor, and a ligature connecting the first anchor and the second anchor with each other so that the second anchor compresses the prostate tissue to secure the opening of the prostatic urethra; and a sheath inserted into the urethra and having a needle, which guides the anchor assembly to be deployed at the prostate gland.

Claims (10)

1. A benign prostatic hyperplasia treatment device comprising:

anchor assemblies including a first anchor configured to be arranged at the outer surface of the prostate gland, which is configured to obstruct the prostatic urethra, a second anchor configured to be arranged inside the prostate gland to be opposed to the first anchor, and a ligature connecting the first anchor and the second anchor with each other so that the second anchor configured to compress the prostate tissue to secure the opening of the prostatic urethra;

a sheath configured to be inserted into the urethra and having a needle, which guides the anchor assembly to be deployed at the prostate gland;

a needle manipulation part for manipulating movement of the needle so that the needle is deployed through an end portion of the sheath;

a thread winder disposed at one side of the needle manipulation part and winding the ligature thereon to adjust intensity with which the anchor assemblies is configured to compress the prostate gland; and

a handle frame part which supports the end portion of the sheath, the needle manipulation part and the thread winder and is configured to be grasped by an operator,

wherein the ligature includes: a length-adjustable loop joined to the first anchor and the second anchor to be adjustable in length; a free end extending from the length-adjustable loop; and a slip knot for connecting the length-adjustable loop to the free end so as to adjust the length of the length-adjustable loop, and

wherein the thread winder winds the free end to adjust the length of the length-adjustable loop so that the second anchor is configured to compress the prostate tissue.

2. The benign prostatic hyperplasia treatment device according to claim 1 , wherein the slip knot is formed below the second anchor or is formed between the first anchor and the second anchor.

3. The benign prostatic hyperplasia treatment device according to claim 1 , wherein the first anchor is accommodated in the needle, and the second anchor is joined to an entrance region of the sheath.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2022
From: CHUNG, YOON HO; PARK, GEON SUN
To: CEDARS HEALTH, INC.
Reel/Frame 061995/0330 →
Priority Claims (1)
KR 10-2020-0109927 · Aug 31, 2020 · national
Continuity (2)
Continuation In Part 17362993 · Jun 30, 2021
Related Publication 20220249219A1 · Aug 11, 2022
References Cited (27)
US 5810848A · Hayhurst · 1998 [cited by examiner]
US 6972027B2 · Fallin · 2005 [cited by examiner]
US 7601165B2 · Stone · 2009 [cited by examiner]
US 8236011B2 · Harris · 2012 [cited by examiner]
US 8790369B2 · Orphanos · 2014 [cited by examiner]
US 9402711B2 · Catanese, III · 2016 [cited by examiner]
US 9750492B2 · Ziniti · 2017 [cited by examiner]
US 10105132B2 · Lamson · 2018 [cited by examiner]
US 10130353B2 · Catanese, III · 2018 [cited by examiner]
US 10143461B2 · Catanese · 2018 [cited by examiner]
US 10265061B2 · Johnston · 2019 [cited by examiner]
US 10299780B2 · Catanese, III · 2019 [cited by examiner]
US 10349932B2 · Catanese, III · 2019 [cited by examiner]
US 10441273B2 · Hirotsuka · 2019 [cited by examiner]
US 20020019649A1 · Sikora · 2002 [cited by examiner]
US 20060190042A1 · Stone · 2006 [cited by examiner]
US 20060217762A1 · Maahs · 2006 [cited by examiner]
US 20080140093A1 · Stone · 2008 [cited by examiner]
US 20080195145A1 · Bonutti · 2008 [cited by examiner]
US 20090112234A1 · Crainich · 2009 [cited by examiner]
US 20100023022A1 · Zeiner · 2010 [cited by examiner]
US 20100023024A1 · Zeiner · 2010 [cited by examiner]
US 20100030262A1 · McLean · 2010 [cited by examiner]
US 20110060349A1 · Cheng · 2011 [cited by examiner]
US 20110082471A1 · Holcomb · 2011 [cited by examiner]
US 20110160747A1 · McLean · 2011 [cited by examiner]
US 20180256142A1 · Tong · 2018 [cited by examiner]